Belinda Lovelace

Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis

Olivia S. Costa, Stuart J. Connolly, Mukul Sharma et al. · Critical Care · 2022 · 66 citations · Full text

The Burden of Opioid-Related Adverse Drug Events on Hospitalized Previously Opioid-Free Surgical Patients

Richard D. Urman, Diane L. Seger, Julie Fiskio et al. · Journal of Patient Safety · 2019 · 64 citations

Comparative analysis of length of stay, hospitalization costs, opioid use, and discharge status among spine surgery patients with postoperative pain management including intravenous versus oral acetaminophen

Ryan N. Hansen, An T. Pham, E. Boing et al. · Current Medical Research and Opinion · 2017 · 60 citations · Full text

The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records

Khurram Jamil, Xingyue Huang, Belinda Lovelace et al. · Journal of Medical Economics · 2019 · 46 citations · Full text

Real-world Management of Oral Factor Xa inhibitor-related Bleeds With Reversal Or Replacement Agents Including Andexanet Alfa and four-factor Prothrombin Complex Concentrate: A Multicenter Study

Craig I Coleman, Paul P. Dobesh, Sherry Danese et al. · Future Cardiology · 2020 · 44 citations